SCWorx’s (WORX) Sell (E+) Rating Reiterated at Weiss Ratings

Weiss Ratings reissued their sell (e+) rating on shares of SCWorx (NASDAQ:WORXFree Report) in a research note released on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen upgraded SCWorx to a “sell” rating in a research report on Saturday, June 14th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, SCWorx has an average rating of “Sell”.

View Our Latest Stock Report on SCWorx

SCWorx Stock Down 11.3%

Shares of WORX stock opened at $0.28 on Wednesday. The stock has a market capitalization of $2.17 million, a PE ratio of -0.26 and a beta of 2.60. SCWorx has a 52-week low of $0.26 and a 52-week high of $3.31. The stock’s 50-day moving average price is $0.31 and its 200 day moving average price is $0.46.

SCWorx (NASDAQ:WORXGet Free Report) last issued its quarterly earnings results on Thursday, August 14th. The company reported ($0.44) earnings per share (EPS) for the quarter. The company had revenue of $0.68 million during the quarter. SCWorx had a negative net margin of 105.74% and a negative return on equity of 58.42%.

SCWorx Company Profile

(Get Free Report)

SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry.

Read More

Receive News & Ratings for SCWorx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SCWorx and related companies with MarketBeat.com's FREE daily email newsletter.